Skip to content

Biohyl Lacto

by UAB Innovative Pharma Baltics EUDAMED

Active European Union

Ref SP4-038

Regulatory status

as of 27 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDD Number477903447BiohylLactoMN Basic UDI-DIDate5 Oct 2026RegisteredStatusActive
European UnionCE/MDR Number477903447BiohylLactoMN Basic UDI-DIDate5 Oct 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/MDD, CE/MDR Active

Certificates

0 certificates · EUDAMED

No notified-body certificate is listed. Devices of this class are self-declared by the manufacturer.

Specification

EUDAMED

Device Name
Biohyl
Model / Reference
SP4-038
Primary DI / UDI-DI
04779034472980
Basic UDI-DI
477903447BiohylLactoMN, B-04779034472980
EMDN Code
U0803 Vaginal devices in the form of solutions/creams/ova/tablets
Device Class
Class I
Market of Registration
Lithuania

Manufacturer details

EUDAMED SRN
LT-MF-000047362

Other devices from UAB Innovative Pharma Baltics

Properties

  • Administering Medicine

Other properties (12)

  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No